PURACAP PHARMACEUTICAL Trademark

Trademark Overview


On Tuesday, October 18, 2022, a trademark application was filed for PURACAP PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the PURACAP PHARMACEUTICAL trademark a serial number of 97636942. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 7, 2023. This trademark is owned by PuraCap Pharmaceutical LLC. The PURACAP PHARMACEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders
puracap pharmaceutical

General Information


Serial Number97636942
Word MarkPURACAP PHARMACEUTICAL
Filing DateTuesday, October 18, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements


Description of MarkThe mark consists of the word "PuraCap" over the word "PHARMACEUTICAL" and surrounded by an elliptical shape with its lower right-quadrant omitted.
Goods and Servicespharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text" PHARMACEUTICAL"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePuraCap Pharmaceutical LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIselin, NJ 08830

Party NamePuraCap Pharmaceutical LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIselin, NJ 08830

Trademark Events


Event DateEvent Description
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 4, 2023EXAMINER'S AMENDMENT ENTERED
Friday, August 4, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 4, 2023EXAMINERS AMENDMENT E-MAILED
Friday, August 4, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 1, 2023ASSIGNED TO EXAMINER
Friday, November 4, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 21, 2022NEW APPLICATION ENTERED